NewGenIvf Group Ltd
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
About NewGenIvf
Services-Misc Health & Allied Services, NEC, SIC 8090
NewGenIvf Group Limited provides fertility and assisted reproductive technology services, assisting individuals and couples seeking fertility treatments. The company offers a suite of fertility solutions, including in vitro fertilization and pre-implantation genetic screening services. Alongside its core fertility operations, the enterprise is diversifying its business activities into digital asset management, real estate development, and mining initiatives, which include acquiring and managing cryptocurrency assets.
The company operates primarily across the Asia-Pacific region, maintaining subsidiaries such as First Fertility PGS Center Limited. It holds its executive and corporate offices in Bangkok, Thailand, and maintains administrative contact facilities in Hong Kong, while maintaining its legal incorporation in the British Virgin Islands.
Summary of the business section of NewGenIvf's latest annual report, written by StockData.
Company profile
Company
- Legal name
- NewGenIvf Group Ltd
- Founded
- 2019
- Headquarters
- Bangkok, W1
- Address
- 13/F, Ps Tower, Sukhumvit 21 Rd (Asoke) 0000
- Phone
- 852-2861-1666
- Employees
- 87, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- D8
- Auditor
- J&S Associate PLT, Kuala Lumpur, Malaysia
Stock & identifiers
- Ticker
- NIVF
- Other tickers
- NIVFW
- Exchange
- Nasdaq
- Shares outstanding
- 0M, Dec 31, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-4 reverse, Oct 12, 2026; 1-for-3 reverse, Sep 1, 2026; 1-for-3 reverse, Jul 6, 2026; 1-for-4 reverse, Mar 16, 2026; 1-for-3 reverse, Jan 26, 2026; 1-for-5 reverse, Dec 1, 2025; 1-for-5 reverse, Aug 4, 2025; 1-for-10 reverse, May 5, 2025; 1-for-20 reverse, Apr 22, 2025
- SEC CIK
- 1981662
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Hei Yue Tina Fong | Chief Marketing Officer, Director | 56,890 |
| Wing Fung Alfred Siu | Chairman & CEO, Director | 56,881 |
| Ho Fai Chung | Chief Financial Officer | – |
| Chung Ho Chan | Chief Financial Officer | – |
| Tsz Hin Vincent Lau | Director | – |
| Chun Tung Patrick Lam | Director | – |
| Kong Yiu Cheung | Director | 3,722,223 |
| Sze Mun Lee | Director | – |
| Chun Wa Tam | Director | – |
| Chan Florianna Ann Chi Wan Ching | Director | – |
| Hok Man Jefferson Au | Director | – |
Employees
Headcount reported in annual reports
“NewGenIvf has 87 full-time employees as of December 31, 2025, of which 72 are based in Thailand, Cambodia and Kyrgyzstan.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 30, 2024 | Late filing | Notification of late filing |
| Mar 1, 2024 | Name change | Name changed from ASPAC I Mini Acquisition Corp. to NewGenIvf Group Ltd |
| Oct 27, 2023 | Merger | Registration of securities for a merger or exchange offer (S-4) |